ADVISORY RESEARCH INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$643,000
+8.4%
25,087
+0.6%
0.06%
+8.6%
Q2 2022$593,000
-49.0%
24,937
-61.3%
0.06%
+205.3%
Q4 2017$1,163,000
+18.1%
64,423
+26.3%
0.02%
+18.8%
Q3 2017$985,000
-22.3%
51,025
-52.5%
0.02%
-20.0%
Q2 2017$1,268,000
-27.8%
107,436
-32.9%
0.02%
-23.1%
Q1 2017$1,756,000160,2190.03%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders